Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction
about
How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial InfarctionAntifibrotic therapies to control cardiac fibrosisIn vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A ReviewSystems biology-opportunities and challenges: the application of proteomics to study the cardiovascular extracellular matrixThe Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart.Extracellular matrix hydrogels from decellularized tissues: Structure and function.Engineering growth factors for regenerative medicine applications.Tailoring material properties of cardiac matrix hydrogels to induce endothelial differentiation of human mesenchymal stem cells.Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.c-kit(+)AT2R(+) Bone Marrow Mononuclear Cell Subset Is a Superior Subset for Cardiac Protection after Myocardial Infarction.Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model.Decellularized zebrafish cardiac extracellular matrix induces mammalian heart regeneration.Developing injectable nanomaterials to repair the heartDecellularized myocardial matrix hydrogels: In basic research and preclinical studies.Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.Engineering an Injectable Muscle-Specific Microenvironment for Improved Cell Delivery Using a Nanofibrous Extracellular Matrix Hydrogel.A novel protein-engineered hepatocyte growth factor analog released via a shear-thinning injectable hydrogel enhances post-infarction ventricular function.Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease.Treatment of Myocardial Infarction with Gene-modified Mesenchymal Stem Cells in a Small Molecular Hydrogel.Stem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue.Extracellular matrix hydrogel therapies: in vivo applications and development.Degradable acetalated dextran microparticles for tunable release of an engineered hepatocyte growth factor fragment.Integrated approaches to spatiotemporally directing angiogenesis in host and engineered tissues.Head-to-head comparison of two engineered cardiac grafts for myocardial repair: From scaffold characterization to pre-clinical testing.
P2860
Q26739723-EB10CE0E-81D5-49FB-AE2E-B84763FCEEECQ26745841-37CBA953-BD95-4430-B01B-71E4FDB76C56Q26775715-6D70AC2E-AEF4-4681-98A3-53BBBAD6C82FQ26799856-2C40F05E-9FA9-43DA-B6C7-57AA1A9B4AADQ28066160-30E99F0E-DC65-4D12-BA5E-11FF5D2FEF69Q33737254-6AC8134B-AC55-4C9F-B57A-F7E8470AE57BQ34546589-762B68A0-7E6A-4EE9-92C0-9458790E6FEFQ35837394-83C3C37E-7AEF-421A-B2A2-5568F336BDDBQ36384613-D8FD03B7-52BB-4E6D-A60D-679475CB16A8Q36915712-714BDD49-C736-4EAE-9876-2722D2FDD4EAQ37081057-71E3EC57-5458-43C5-81D0-A4B28AA5C4FCQ37099897-ACDFA067-0A33-4370-B151-5E5D007DDEFEQ37603874-664793DD-225A-4976-B707-BF67637F900AQ38416005-6D5919DB-8C65-4C71-B774-2E52A0624A83Q38521799-9D8D5797-518B-4B3B-9E78-2D41A4E35C89Q39197932-2720A375-4755-4CF5-910C-22F095816A78Q46443054-2C5D56D3-3FC7-48DC-B3F8-6A98C2AFA4C9Q46567132-35A1E6A1-0D85-4163-B9C6-475002C81AEEQ46813976-AE86B152-7296-4C54-B936-34858201CFDFQ46837475-F1D5520D-0FAA-4048-B616-8E47D6EDFE0BQ47215752-1C8C1D5B-A03F-41EB-9867-A31FFA6F5332Q47222356-352B13C1-D8C9-4CF9-87D5-4997592901B1Q49263652-0EECFEC6-13EE-4D21-AE13-1881213BE9DAQ49684144-70BC718A-C470-4677-AAA4-5287CC383105Q54987414-C5EBADD3-49F9-4E27-9744-C05B60D400F7
P2860
Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Delivery of an engineered HGF ...... ing post-myocardial infarction
@ast
Delivery of an engineered HGF ...... ing post-myocardial infarction
@en
type
label
Delivery of an engineered HGF ...... ing post-myocardial infarction
@ast
Delivery of an engineered HGF ...... ing post-myocardial infarction
@en
prefLabel
Delivery of an engineered HGF ...... ing post-myocardial infarction
@ast
Delivery of an engineered HGF ...... ing post-myocardial infarction
@en
P2093
P2860
P1433
P1476
Delivery of an engineered HGF ...... ing post-myocardial infarction
@en
P2093
Aboli A Rane
Adam Munoz
Anthony N DeMaria
Cassie J Liu
Jennifer R Cochran
Karen L Christman
Nikhil Rao
Oi Ling Kwan
Pamela J Schup-Magoffin
Raymond Wang
P2860
P356
10.1016/J.BIOMATERIALS.2014.12.021
P577
2015-01-13T00:00:00Z